Back to search

Article

HypoxamicroRNA-210 protects against hepatic steatosis by inhibiting CIDEC expression

2025-12-20

Abstract excerpt

<h4>Background and Aims:</h4> Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major global health burden. Although hypoxia is known to contribute to MASLD pathogenesis, the role of hypoxia signaling remains poorly defined. We investigated whether HypoxamicroRNA-210 (miR-210), a key hypoxia-inducible microRNA, regulates hepatic lipid metabolism and MASLD development. <h4>Methods:</h4> Serum...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
54cb63b6-d00d-58f7-8d2d-50a4d98ab90b
DOI
10.64898/2025.12.19.695309
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HypoxamicroRNA-210 protects against hepatic steatosis by inhibiting CIDEC expressionDOI 10.64898/2025.12.19.695309
Select a neighboring publication to make it the new centre.